CYP-2C19 was then tested as a potential antigen in 24 control sera from patients with idiopathic AIH, 26 patients with PBC, 16 patients with APS-1, and 50 healthy controls. The gene discussed is CYP2C19; the disease is autoimmune polyendocrine syndrome type 1.